********** downramps Resapp, page-144

The only emotions Motley stirred Tobes11 were emotions of shock/distrust/anger and embarrassment that a broker who hasn't done his full research on the company could even submit such an article.

Sounded like Mr Walker only read one page of financials and noticed that they had no revenue yet, well yes that is because RAP is developing/testing/gaining submission to the FDA and creating a new technology that has not gone to market yet.

Maybe more research and understanding of a product/stock is needed before the uninitiated go spruiking half truths.